Introduction {#s1}
============

Depressive disorder is one of the most prevalent psychiatric disorders, affecting around 340 million people worldwide,[@R1] and it is associated with a substantial deterioration in quality of life and economic loss in the community and the workplace.[@R2] [@R3] Thus, the primary prevention of depressive disorder is an important strategy for global mental health. In addition, stress has enormous socioeconomic implications for all spheres of employment in terms of absenteeism, staff turnover, lost productivity, poor morale, etc.[@R4] [@R5] Although the burden of stress and depression on the workplace is substantial,[@R6] few studies aiming to prevent psychosocial problems have been conducted.

Two previous meta-analyses have shown that cognitive behaviour therapy (CBT) is an effective preventive measure for major depressive disorder. One meta-analysis reported that the risk of depressive disorder decreased by 16% on average in the intervention group and summarised 15 various types of CBTs.[@R7] Another meta-analysis of randomised controlled trials (RCTs) with a CBT program, 'Coping with Depression (CwD)',[@R8] showed that the program can also prevent major depressive disorder and indicated a 38% decrease in the risk among participants in the program.[@R9] However, major limitations exist in the dissemination of these CBT interventions: the programs require that professionals be well trained in CBT;[@R10] time, cost and stigma are other barriers to access to a CBT program.[@R13]

An innovative way to deliver CBT-based treatment widely is by using computerised CBT (CCBT) and CCBT via the internet (iCBT). Both CCBT and iCBT programs teach basic information and skills based on the same CBT principles as face-to-face CBT programs, with a highly structured format comprised of educational lessons, homework assignments and supplementary resources.[@R14] Previous studies have shown a significant positive treatment effect of CCBT and iCBT programs on depression and anxiety in the clinical setting.[@R15] An iCBT program is particularly beneficial with its high anonymity[@R16] and high accessibility.[@R17] Recently, there have been increasing applications of iCBT for preventing depression. Using self-reported symptoms of depression as an outcome, one study of adolescents reported a significant prevention effect of iCBT programs, though it included only male participants.[@R18] In addition, one study of university students[@R19] and one community-based study[@R20] reported a significant effect of iCBT programs on improving depressive symptoms in non-clinical settings. However, one community-based study failed to show a significant effect.[@R21] We also have reported that a six-session iCBT program successfully improved symptoms of depression in an RCT in the workplace.[@R22] However, a search of the literature revealed only one previous RCT (conducted by the authors),[@R23] which investigated the effect of an iCBT program on reducing the risk of major depressive episodes (MDEs) diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV diagnostic criteria.[@R24] The control group was also provided with a treatment program during the follow-up.[@R23] Thus, evidence for the effect of an iCBT on reducing risk of MDE is still very limited.

A previous follow-up survey of employees in a company showed that the incidence of DSM-IV major depressive disorder was 2.8% during 12 months in Japan.[@R25] If we randomise about 8000 participants equally to intervention and control groups (4000 in each group), the total incidence will be 146 (55 and 91 in the intervention and control groups, respectively), assuming that incidence ratio (IR)=0.62 (see sample size calculation in method and analysis for details). Since the number of participants will be large, it would not be possible to conduct face-to-face or even telephone interviews to ascertain the occurrence of MDE during the follow-up; it is a feasible strategy to use the web-based self-report version of a standard structured interview, such as the WHO-Composite International Diagnostic Interview (CIDI) V.3.0 depression section,[@R26] [@R27] which has been shown to have good concordance with the clinical diagnosis of MDE[@R28] and an acceptable 1-year test-retest reproducibility.[@R25] While a self-report assessment of MDE is clearly a major limitation, only such an instrument is feasible for a large-scale trial to reduce the risk of MDE diagnosed strictly following DSM-IV/DSM-5 criteria, which cannot be made by a symptom checklist.

Objectives {#s1a}
----------

The present study is a 12-month follow-up large-scale RCT. An improved iCBT program, which was based on the results of the previous study,[@R22] will be used. The purposes of this randomised controlled study are as follows: (1) to decrease the risk of DSM-IV/DSM-5-defined MDE through the 12-month follow-up among workers in Japan; (2) to examine the effects of the iCBT program on improving the symptoms of depression at 3-month, 6-month and 12-month follow-ups among workers who have subthreshold depressive symptoms in Japan; (3) to examine the effects of the iCBT program on improving work engagement and work performance at 3-month, 6-month and 12-month follow-ups among workers in Japan; and (4) to examine the cost-effectiveness of the iCBT program. We expect that: (1) the iCBT program will reduce the risk of MDE during the 12-month follow-up; (2) it will improve symptoms of depression at 3-month, 6-month and 12-month follow-ups among workers who have subthreshold depressive symptoms at baseline; (3) it will improve work engagement and work performance at 3-month, 6-month and 12-month follow-ups; and (4) the program will be cost-effective.

Trial design {#s1b}
------------

The study will be a two-arm, parallel-group, treatment as usual (TAU)-controlled, non-blinded randomised study. The allocation ratio of the intervention group to the control group is 1 to 1. Participants will be randomly allocated either to the intervention group or to the control group after they have completed a baseline online questionnaire survey. Online follow-up surveys will be conducted 3, 6 and 12 months after the baseline. The study protocol was registered at the UMIN Clinical Trials Registry (UMIN-CTR; ID=UMIN000014146). This protocol manuscript was reported according to the SPIRIT guideline checklist.

Methods and analysis {#s2}
====================

Participants {#s2a}
------------

Working men and women will be selected according to the following criteria:

Inclusion criteria Age 20--60 at study entry.Currently employed full-time by the business company.Can access the internet via a PC at home or at his/her workplace, since the server software used in this study allows access only from a PC, but not from mobile devices such as smartphones.

Exclusion criteria Non-regular or part-time employees.Sick leave for 15 or more days for a physical or mental condition in the past 3 months.Current treatment for a mental health problem from a mental health professional.An MDE within the past month as ascertained by the web version of the Japanese WHO-CIDI V.3.0.A lifetime history of bipolar disorder as ascertained by the web version of the Japanese WHO-CIDI V.3.0.

Procedure {#s2b}
---------

[Figure 1](#BMJOPEN2015007590F1){ref-type="fig"} shows the participant flow chart of this trial. Our previous RCT reported that 47.5% of employees who received invitation emails completed a baseline survey and 10% of them had to be excluded.[@R22] For this study, the clinical research coordinator (CRC) will send out invitations to 20 000 employees, of whom 9000 are expected to give informed consent, and 8100 are expected to be eligible. These 8100 will be randomised either to the intervention group (n=4050) or to the control group (n=4050). They will be allowed to complete the six lessons within 10 weeks after the baseline survey. Those in the control group can receive the iCBT after 12 months. An invitation email to all workers in a corporate group will direct them to a website that includes a full explanation of the study. After reading the explanation of the study on the website, they will be asked to click on an 'agree' button to give their consent to participate in the study; then they will proceed to the baseline questionnaire page. If a candidate clicks on a 'disagree' button, the website page will close. In order for the randomisation and start of intervention to be as close as possible, the CRC will endeavour to randomise the participants immediately after closing the application and send an email with the iCBT program course description as soon as possible. A computer system for automating the randomisation of candidates on a first-come, first-served basis is not available.

![Participant flow chart.](bmjopen2015007590f01){#BMJOPEN2015007590F1}

Intervention program {#s2c}
--------------------

The iCBT program called *Internet CBT Program: Useful Mental Health Solutions Series for Business* is a 6-week web-based training course that provides CBT-based stress management skills.[@R22] This program is structured in six lessons, with one lesson per week. About 30 min are needed for each lesson, including the homework. This program can be used anywhere the internet is available.

One of the unique features of the program is that training is provided along with a Manga (Japanese comic) story of a psychologist and a client to facilitate the understanding of the participants. Several merits of using a comic story with Manga characters have been acknowledged in research on education in school. First, it helps motivate participants to stay in the program.[@R29] Second, it facilitates easy learning. A program with text combined with comic stories is easier for learners to understand compared with a text-only program.[@R29] [@R30] Third, using a comic story fosters learners' interest in the program.[@R30] These merits might be applicable to education in the workplace because most Japanese people of working age are familiar with comics.

The present iCBT program was developed with two established CBT packages as its basis. One is the cognitive therapy program developed by Beck.[@R31] The other is the 'CwD' program developed by Lewinsohn.[@R8] The CBT skill components included in the program are: self-monitoring, cognitive restructuring, assertiveness, problem-solving and relaxation. The behavioural activation technique, a main component of the CwD, is not included in the present RCT in order to be consistent with the previous RCT.[@R22] [@R23] At the end of each lesson, participants will be asked to submit homework on a voluntary basis, to receive feedback from trained staff (eg, clinical psychologists) to facilitate their understanding. Feedback will be sent to the participants within 2 days after their submission.

[Table 1](#BMJOPEN2015007590TB1){ref-type="table"} shows the contents of the iCBT program. The program includes self-monitoring skills (in lesson 2), cognitive restructuring skills (in lessons 3 and 4), assertiveness skills (in lesson 5), problem-solving skills (in lesson 6) and relaxation skills (in lesson 4). In this study, the cognitive restructuring method was adopted as the primary and main cognitive approach, as it had previously been shown to be effective in reducing depression.[@R32] Assertiveness and problem-solving training, as well as training in relaxation, were chosen as supplementary behavioural approaches to enhance the effect of the program.

###### 

Contents of the iCBT program

  Lesson number   Title                                                   Contents
  --------------- ------------------------------------------------------- --------------------------------------------------------------------------------
  1               Learning about stress                                   Learning about a psychological stress model modified for this iCBT program
  2               Knack for a self-case formulation based on a CB model   Learning about a CB model and how to do self-monitoring based on CBT
  3               Try cognitive restructuring, part 1                     Learning about cognitive restructuring
  4               Try cognitive restructuring, part 2                     Learning about cognitive restructuring and relaxation using a breathing method
  5               Knack for communication                                 Learning about active listening and assertiveness
  6               How to solve your problem effectively                   Learning about problem-solving methods

CB, cognitive behavioural; iCBT, internet-based cognitive behavioural therapy.

### Lesson 1: learning about stress {#s2c1}

In this lesson, participants learn about a psychological stress model.[@R33] A guiding character, clinical psychologist Miss Rino, speaks about the relationship between stressors and stress reactions. Homework in this lesson includes respondents self-checking their stressors and stress reactions to help them identify these factors/conditions.

### Lesson 2: knack for self-case formulation based on a CB model {#s2c2}

In this lesson, participants learn about a cognitive behavioural (CB) model, especially the five-part model ('five-part' refers to five areas: situation, thoughts, emotions, behaviour and physical feelings)[@R34] and a self-case formulation based on this model. Case formulation is a method used to understand the problem of a client.[@R35] Case formulation is necessary for clients to choose an appropriate approach to change the vicious circles of these five areas. Miss Rino introduces a five-part CB model using a vignette of a worker with a work-related problem. Homework in this lesson includes self-monitoring using the five-part model.

### Lesson 3: try cognitive restructuring part 1 {#s2c3}

In this lesson, participants learn about Beck's cognitive model and the acquired self-monitoring skills based on this model. The model postulates that an individual's mood and behaviour are affected by his/her automatic thoughts, which are shaped by dysfunctional schemas.[@R36] The cognitive restructuring technique is one of the standard cognitive approaches of CBT utilised to change an automatic negative thought into an actual, realistic and flexible thought.[@R31] Miss Rino gives a lecture on a cognitive ABC model (Activating/Actual event, Belief, and Consequence)[@R31] [@R37] [@R38] and on identifying the automatic thoughts that cause a negative mood. Homework in this lesson includes a self-monitoring exercise of participants' negative mood caused by an automatic thought in a particular situation selected by the participants.

### Lesson 4: try cognitive restructuring, part 2 {#s2c4}

In this lesson, participants learn cognitive restructuring skills. Miss Rino teaches participants how to change an automatic negative thought into an actual thought. In the latter half of the lesson, participants learn a relaxation technique using a breathing method. Relaxation techniques are often added to the CBT intervention for workers, and they have shown significant effects on improving depression.[@R39] Homework in this lesson includes an exercise on cognitive restructuring. On the basis of the homework of lesson 3, participants try to reconsider the rationale behind the automatic thought, seek alternative thinking and replace automatic thought with rational thinking.

### Lesson 5: knack for communication {#s2c5}

In this lesson, participants learn active listening (AL) and assertiveness skills. AL is a way of listening and responding to another person with an aim to improve mutual understanding.[@R40] It is applied to non-therapeutic situations as a tool for better communication. Assertiveness is typically defined as the legitimate and honest expression of one\'s personal rights, feelings, beliefs and interests without violating or denying the rights of others.[@R41] [@R42] In order to communicate assertively, the DESC (Describe, Express, Specify, and Choose or Consequence) script is used.[@R43] Assertiveness training can help employees change their job environments by teaching them to appropriately communicate their concerns to supervisors, coworkers or subordinates.[@R44] Assertiveness training has often been used as a supplemental component of stress management interventions in the workplace.[@R45] In this lesson, Miss Rino also teaches AL and assertiveness skills based on the DESC script. Homework in this lesson includes an assertiveness exercise based on the DESC script.

### Lesson 6: how to solve your problem effectively {#s2c6}

In this lesson, participants learn a problem-solving technique based on problem-solving therapy. Problem-solving therapy is a CB intervention that focuses on training adaptive problem-solving attitudes and skills.[@R46] A rational problem-solving style involves the deliberate and systematic application of four major problem-solving skills: (1) problem definition and formulation, (2) generation of alternative solutions, (3) decision-making and (4) solution implementation and verification.[@R47] Problem-solving training is often used in stress management intervention in the workplace.[@R39] [@R48] In this lesson, Miss Rino teaches participants how to sort out the problem and make a list of solutions using problem-solving methods. Homework in this lesson includes a problem-solving exercise.

Intervention group {#s2d}
------------------

Participants in the intervention group will complete six weekly lessons and homework within the iCBT program. They will be allowed to complete the six lessons and submit their homework within 10 weeks after the baseline survey. The participants will be reminded by email to complete each lesson and/or submit their homework if they have not already done so. Reminders will be sent from the research office to the participants every Monday.

Control group {#s2e}
-------------

Participants in the control group will be able to use an internal employee assistance program service, such as consulting with a physician or a psychologist, and group- or online education/training programs for promoting mental health, as a TAU. These programs contained few descriptions of CBT knowledge and skills.

Outcomes {#s2f}
--------

[Table 2](#BMJOPEN2015007590TB2){ref-type="table"} shows an overview of the outcome measures. The primary outcome measure will be assessed at the baseline, and at the 6-month and 12-month follow-ups. All secondary outcomes, except for the time preference, will be assessed at the baseline, the 3-month follow-up (end of acute phase treatment), the 6-month follow-up and the 12-month follow-up. The time preference will be assessed at the baseline and the 12-month follow-up. Non-respondents will receive reminder email at least two times from the research centre for each of the follow-up surveys, at 3, 6 and 12-months.

###### 

Overview of outcome measures

  Measurement                                                         Aim                                                       Baseline (T1)   3-Month follow-up (T2)   6-Month follow-up (T3)   12-Month follow-up (T4)
  ------------------------------------------------------------------- --------------------------------------------------------- --------------- ------------------------ ------------------------ -------------------------
  The web version of the Japanese WHO-CIDI V.3.0 depression section   Duration before the onset of a major depressive episode   x                                        x                        x
  BDI-II                                                              Severity of depression                                    x               x                        x                        x
  K6                                                                  Severity of psychological distress                        x               x                        x                        x
  HPQ                                                                 Work performance                                          x               x                        x                        x
  Sick leave days                                                     Sick leave days in the past 3 months                      x               x                        x                        x
  UWES                                                                Work engagement                                           x               x                        x                        x
  Time preference                                                     Time preference                                           x                                                                 x
  EQ-5D                                                               Quality of life                                           x               x                        x                        x
  Healthcare use                                                      Healthcare use                                            x               x                        x                        x

BDI-II, Beck Depression Inventory II; HPQ, Health and Work Performance Questionnaire; K6, Kessler Psychological Distress Scale; UWES, Utrecht Work Engagement Scale.

### Primary outcome {#s2f1}

#### Incidence of MDE {#s2f1a}

The primary outcome measure is the onset of MDE during the 12-month follow-up. To collect accurate information of the onset of MDE, assessments will be conducted at the 6-month and 12-month follow-ups. The onset of MDE during the follow-up will be assessed using the web version of the Japanese WHO-CIDI V.3.0 depression section[@R26] [@R27] according to DSM, Fourth Edition, Text Revision (DSM-IV-TR) criteria. The face-to-face version of WHO-CIDI V.3.0 was translated into Japanese and proved to be valid for diagnosing MDE.[@R49] The web version asks respondents the same set of questions and uses the skip logics of the depression section, and a diagnosis of MDE is automatically produced by a computer program using an algorithm specific to WHO-CIDI V.3.0. The web version has been shown to have a good concordance with the clinical diagnosis of MDE[@R28] and to be reliable in a 1-year test-retest survey.[@R25] While the WHO CIDI V.3.0 was originally designed to produce a diagnosis according to DSM-IV-TR criteria, the instrument can also produce a diagnosis of MDE based on DSM-5 criteria.[@R50]

Since respondents will be asked to report any episode of MDE, along with the month of onset, at both the 6-month and 12-month follow-ups, there is a possibility of discrepancy in the reported onset information. In the case of such discrepancy, the reported onset at the 6-month follow-up will be used for the purposes of this study.

### Secondary outcomes {#s2f2}

#### Beck Depression Inventory-II {#s2f2a}

The Beck Depression Inventory II (BDI-II) is a 21-item self-report inventory that measures depressive symptoms such as sadness, pessimism, suicidal thoughts or wishes, tiredness or fatigue, loss of energy, and loss of pleasure, among others.[@R51] [@R52] Each item is scored on a scale ranging from 0 to 3, with a higher score indicating more serious depressive symptoms.

#### Kessler\'s Psychological Distress Scale {#s2f2b}

Psychological distress will be measured by the Japanese version of Kessler\'s Psychological Distress Scale (K6).[@R53] [@R54] K6 consists of six items assessing the frequency with which respondents have experienced symptoms of psychological distress during the past 30 days. The response options range from 0 (none of the time) to 4 (all of the time). The internal reliability and validity found in previous studies are acceptable.[@R53]

#### Health and Productivity Questionnaire {#s2f2c}

The WHO Health and Productivity Questionnaire (HPQ) is a self-report instrument designed to estimate the workplace costs of health problems in terms of self-reported sickness absence (absenteeism) and reduced job performance (presenteeism).[@R55] Previous studies have documented significant associations (r=0.61--0.87) of HPQ work hours assessments with payroll records[@R55] and job performance assessments with supervisor ratings (r=0.52),[@R56] as well as other administrative records (area under the curve, 0.58--0.72).[@R27] Respondents will be asked to rate their overall work performance during the past 4 weeks. The item will be scored on an 11-point scale ranging from 0 (worst possible performance) to 10 (best possible performance). High scores indicate a high degree of perceived work performance.

#### Sick leave days during the past 3 months {#s2f2d}

Respondents will be asked to report the number of sick leave days they took during the past 3 month.

#### Utrecht Work Engagement Scale {#s2f2e}

Work engagement will be assessed using the short form of the Japanese version of the Utrecht Work Engagement Scale (UWES).[@R57] The UWES consists of three subscales (ie, vigour, dedication, absorption) comprising nine items. Items are scored on a seven-point scale ranging from 0 (never) to 6 (always). Examples of items are "At my job, I feel strong and vigorous" (vigour), "I am enthusiastic about my job" (dedication) and "I am immersed in my work" (absorption). A total score is calculated from all nine items.

#### Time preference (time discounting) {#s2f2f}

Time preference (time discounting) is one\'s relative valuation for having something (eg, money) currently compared with its valuation at a later date. It may moderate the effect of an iCBT program. Among others,[@R58] in this study, time preference is assessed by the following procedure.[@R59] [@R60] The respondents will be asked to choose between two options, A and B. The respondent receives 1 million yen (around US\$12 000) in a month when he/she chooses option A, while he/she receives a different amount in 13 months when he/she chooses option B. This question consists of nine choices (see [table 3](#BMJOPEN2015007590TB3){ref-type="table"}). For example, for the sixth choice, the respondents compare 1 million yen today to 1 020 000 yen (around US\$12 240) in 13 months. In this case, choosing option B instead of option A is the same as receiving a 2% annual increase. The questionnaire is shown in [table 3](#BMJOPEN2015007590TB3){ref-type="table"}, where the amount received under option A is specified as 1 million yen and the imputed interest rate for option B changes from −5% to over 10%.

###### 

Questionnaire to elicit the time-discount rate

  Option A (receipt in a month)   Option B (receipt in 13 months)   Interest rate (annual), %   Circle A or B   
  ------------------------------- --------------------------------- --------------------------- --------------- ---
  1 million yen                   950 000 yen                       −5                          A               B
  1 million yen                   1 million yen                     0                           A               B
  1 million yen                   1 001 000 yen                     0.10                        A               B
  1 million yen                   1 005 000 yen                     0.50                        A               B
  1 million yen                   1 010 000 yen                     1                           A               B
  1 million yen                   1 020 000 yen                     2                           A               B
  1 million yen                   1 060 000 yen                     6                           A               B
  1 million yen                   1 100 000 yen                     10                          A               B
  1 million yen                   Over 1 100 000 yen                Over 10                     A               B

Suppose you have two mutually exclusive options to receive some money. You may choose option 'A' to receive 1 million yen in a month; or option 'B' to receive a different amount in 13 months. Compare the amounts and delay until its receipt in option 'A' with option 'B' and indicate which option you would prefer for each pair of all nine choice pairs.

#### Quality of life {#s2f2g}

Health-related quality of life will be assessed with the EQ-5D.[@R61] The EQ-5D consists of five items covering five dimensions (mobility, self-care, usual activities, pain/discomfort and anxiety/depression), each of which is rated as causing 'no problems' to 'unable to', and a visual analogue scale. It is a widely applied quality of life instrument, and its reliability and validity are well established.[@R61]

### Key economic outcomes {#s2f3}

#### Clinical end points {#s2f3a}

A cost-effectiveness analysis will be based on the main outcome of depression-free years gained. Depression-free years will be assessed by calculating the difference in follow-up lengths and the duration of any MDE (ie, period of time in weeks that a person meets DSM-IV criteria). In the cost-utility analysis, quality-adjusted life years (QALYs) will be the clinical end point. QALYs will be obtained from the EQ-5D.

#### Costs {#s2f3b}

Direct medical costs will be estimated from the questions about *healthcare use*. Indirect costs stemming from production losses due to absenteeism and presenteeism will be assessed with the WHO HPQ.[@R55]

#### Healthcare use {#s2f3c}

Respondents will be asked to report on their healthcare use at any time during the past 3 months as follows: (1) consultation with a general practitioner (if yes, the number of times); (2) history and number of hospitalisations (if yes, the number of days of hospitalisation); (3) use of medication of any kind; and (4) use of consultation with an industrial physician or the employee assistance program (if yes, the number of times).

Sample size calculation {#s2g}
-----------------------

A meta-analysis of CBT interventions using the 'CwD' program reported that the average effect size (IR) for prevention of MDE was 0.62 (95% CI 0.43 to 0.91) at post-test.[@R9] A follow-up survey of employees in a company showed that the incidence of major depressive disorder was 2.8% during 12 months.[@R25] We applied a method proposed by Rubinstein *et al*[@R62] to calculate a minimal sample size and a statistical power for a proportional hazard model analysis. Thus, if we equally randomise 8272 to an intervention group and control group (4136 participants in each group), we will have 90% power to detect a treatment effect, assuming that IR=0.62. However, these calculations ignore dropout. We expect that 75% will complete our 12-month follow-up, resulting in 3102 respondents in each group at 12 months. In this situation, we will have 80% power to detect the IR of 0.62.

On the other hand, a previous systematic review has shown that the incidence of major depressive disorder was greater in participants with subthreshold depressive symptoms than in participants without subthreshold depressive symptoms.[@R63] By stratifying participants according to K6, we will conduct subgroup analyses targeting the high-risk group.

Randomisation {#s2h}
-------------

Participants who fulfil the inclusion criteria will be randomly allocated to intervention or control groups. Stratified permuted-block randomisation will be conducted as well. Participants will be stratified into 16 strata according to two factors: K6 score (5 or greater or less than 5) in the baseline survey and the eight workplaces to which they belong. The intervention effect may vary according to the severity of psychological distress at baseline. In addition to the analysis of the whole sample (to examine the universal intervention effect), we will also analyse data by a priori-defined subgroups (to examine the selective intervention effect). A stratified permuted-block random table will be generated by an independent biostatistician. Enrolment will be conducted by a CRC, and assignment will be conducted by an independent research assistant. The stratified permuted-block random table will be password protected and blinded to the researcher. Only the research assistant will be able to access it during the work of random allocation.

Statistical methods {#s2i}
-------------------

### Clinical efficacy {#s2i1}

A survival analysis will be conducted to test for the effectiveness of the intervention by comparing the survival time not having an MDE between the intervention and control groups. The survival time of each participant was calculated as months from baseline to the onset of MDE or the termination of the observation. The length of follow-up for each participant will be represented by either the number of months between the baseline and the onset of MDE or the end of the 12-month follow-up period (6-month follow-up if a respondent dropped out at the 12-month follow-up), whichever comes first. The cumulative incidence of MDE at the 6-month and 12-month follow-ups as well as event-free survivals in every follow-up month will be estimated by the Kaplan-Meier method, and the statistical significance of the difference between the cumulative proportions of having an MDE at the 6-month and 12-month follow-ups in the intervention and control groups will be tested. A log-rank test will be conducted to test the difference in the survival probabilities between the intervention and control groups. A single covariate Cox discrete time hazard model will be used to test the difference and to estimate the HR and the 95% CIs of having an MDE in the intervention group compared with the control group. The intervention effect will also be estimated, adjusting for dependent censoring using the inverse probability of censoring weighted method for conducting a sensitivity analysis.[@R64] A similar analysis will also be conducted using an alternative case definition, such as having a moderate level of depression (a BDI-II score of 20 or above).

For secondary outcomes (ie, symptoms of depression), a mixed model for repeated measures conditional growth model analysis will be conducted using a group (intervention and control)\* time (baseline, 3-month, 6-month and 12-month follow-ups) interaction as an indicator of intervention effect. An intention-to-treat analysis will be conducted as well, using the mixed model for repeated measures conditional growth model analysis. Effect sizes and 95% CIs will be calculated using Cohen\'s d among those who completed the questionnaire at baseline and at a follow-up. The values of 0.2, 0.5 and 0.8 are generally interpreted as being suggestive of small, medium and large effects, respectively.[@R65] In addition, the number needed to treat to reduce depressive symptoms or psychological distress to achieve improvement from subthreshold depression will be calculated. Referencing the cut-off scores of BDI-II and K6 of previous studies,[@R51] [@R66] all statistical analyses will be conducted using the SPSS Statistics V.21.0.

### Subgroup analysis {#s2i2}

The effectiveness of the program may differ according to the initial severity of depression. We will therefore use, as one stratification factor, high/low subthreshold depression (ie, participants who scored 5 or more in K6) at the baseline survey and analyse the results according to a priori-defined subgroups (selective intervention effect).

### Economic analysis {#s2i3}

In the cost-effectiveness analysis, the incremental cost-effectiveness ratio (ICER) will be stated as costs per depression-free months gained, whereas the ICER in the cost-utility analysis will represent the costs per quality-adjusted life month gained. Bootstrapping will be used to test the robustness of the ICERs and to quantify the uncertainty around the ratios that will be graphically represented on a cost-effectiveness plane.

Data monitoring {#s2j}
---------------

A Data and Safety Monitoring Board (DSMB) will be set up, including an independent chair and at least two independent members. The DSMB will meet every 3 months after the first client is randomised. The purpose of the meetings will be to review the report prepared by the CRC. The CRC will prepare DSMB reports to monitor recruitment progress and data collection (eg, percentage completing each follow-up).

Ethics and dissemination {#s3}
========================

Ethical and safety considerations {#s3a}
---------------------------------

We have prepared a website that contains a full explanation of the study. Before the baseline survey, participants will be invited to read the explanation on the website and asked to click on an 'agree' button to show their consent to participate in the study. They will then proceed to a baseline questionnaire page. Candidates will be fully informed that their participation is totally voluntary, that even after voluntarily participating they can withdraw from the study without stating the reason, and that neither participation nor withdrawal will cause any advantage or disadvantage to them. Written consent is not required by the Ethical Guidelines for Biomedical Research Involving Human Subjects, Japan; the Research Ethics Review Board of Graduate School of Medicine/Faculty of Medicine, the University of Tokyo has approved this procedure to obtain the participants' consent.

Data confidentiality {#s3b}
--------------------

The survey data will be temporarily stored on a server placed at the Department of Mental Health, Graduate School of Medicine, the University of Tokyo. After the survey, the collected data will be moved to a password-locked stand-alone PC. The collected data will be stored as linkable anonymising data. The data will be accessible only by the CRC.

Dissemination of research findings {#s3c}
----------------------------------

The main findings of this study will be disseminated via publications in peer-reviewed international journals. Presentations of study findings will also be offered at relevant research conferences, and local academic symposia and seminars.

Strengths and limitations {#s3d}
-------------------------

The greatest strength of this study design is its focus on the effect of the iCBT program on preventing the onset of MDE using a large-scale RCT design in a healthy working population. This study is also intended to add evidence for the effect of CBT programs on positive health outcomes (eg, work engagement and work performance) and economic evaluation of iCBT on the primary prevention strategy among healthy workers.

One of the major weaknesses of this study is that an MDE will be measured by self-report, which may be affected by the perception of the participants or by situational factors at work. The validity of the web-based CIDI depression section has been established partially but needs further clarification and refinement. The other limitation is that the participants will be recruited from one corporate group in Japan. Most of them have their own PCs in their offices or homes. The participants may also be assumed to have experience with using a PC and studying in online programs. Therefore, generalisation of the findings to populations that do not share the characteristics of the participants may be limited.
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